| NCT ID | NCT06741631 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | HIV/AIDS |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,200 participants |
| Start Date | 2025-01-10 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,200 participants in total. It began in 2025-01-10 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Eligibility Criteria
Inclusion Criteria: * Be between 16-29 years of age; * Sex assigned at birth is male and identify gender as male or non-binary; * Understand and read English; * Live within US and its territories; * Own or have access to a smartphone; * Self-report anal sex with someone who has a penis in the last 12 months; and * Be HIV-negative or status unknown Exclusion Criteria: * Individuals who identify as transgender
Contact & Investigator
Rebecca Schnall, PhD, MPH
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT06741631 clinical trial?
This trial is open to male participants only, aged 16 Years or older, up to 29 Years, studying HIV/AIDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06741631 currently recruiting?
Yes, NCT06741631 is actively recruiting participants. Contact the research team at rb897@columbia.edu for enrollment information.
Where is the NCT06741631 trial being conducted?
This trial is being conducted at Chicago, United States, New York, United States.
Who is sponsoring the NCT06741631 clinical trial?
NCT06741631 is sponsored by Columbia University. The principal investigator is Rebecca Schnall, PhD, MPH at Columbia University. The trial plans to enroll 3,200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.